BackgroundNaturally acquired immunity to malaria may involve different immune mechanisms working in concert, however, their respective contributions and potential antigenic targets have not been clearly established. Here, we assessed the roles of opsonic phagocytosis and antibody-mediated merozoite growth inhibition inPlasmodium falciparum (P. falciparum)infection outcomes in Ghanaian children.MethodsThe levels of merozoite opsonic phagocytosis, growth inhibition activities and sixP. falciparumantigen-specific IgG of plasma samples from children (n=238, aged 0.5 to 13 years) were measured at baseline prior to the malaria seasons in southern Ghana. The children were then actively and passively followed up for febrile malaria and asymptomaticP. falciparuminfection detection in a 50-week longitudinal cohort.P. falciparuminfection outcome was modelled as a function of the measured immune parameters while accounting for important demographic factors.ResultsHigh plasma activity of opsonic phagocytosis [adjusted odds ratio (aOR)= 0.16; 95%CI= 0.05 - 0.50, p = 0.002], and growth inhibition (aOR=0.15; 95% CI = 0.04-0.47; p = 0.001) were individually associated with protection against febrile malaria. There was no evidence of correlation (b= 0.13; 95% CI= -0.04-0.30; p=0.14) between the two assays. IgG antibodies against MSPDBL1 correlated with opsonic phagocytosis (OP) while IgG againstPfRh2a correlated with growth inhibition. Notably, IgG antibodies against RON4 correlated with both assays.ConclusionOpsonic phagocytosis and growth inhibition are protective immune mechanisms against malaria that may be acting independently to confer overall protection. Vaccines incorporating RON4 may benefit from both immune mechanisms.